Cuss Francis M Insider Trades

Insider Trading History

Track insider trading activity for Cuss Francis M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mural Oncology plc
Mural Oncology plc MURA
Director
Holding Value $0 0 shares
Last Trade
Dec 05, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$65.5k 32,120 shares
$2.04
$2.04
Mural Oncology plc
Mural Oncology plc MURA
Director
Holding Value $17.6k 8,637 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.1k 8,637 shares
$2.56
$2.04
Mural Oncology plc
Mural Oncology plc MURA
Director
Holding Value $30.6k 15,021 shares
Last Trade
Dec 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$54.2k 15,021 shares
$3.61
$2.04
Rubius Therapeutics
Rubius Therapeutics RUBY
Director
Holding Value $1.43k 25,000 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31k 25,000 shares
$1.24
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Director
Holding Value $1.43k 25,000 shares
Last Trade
May 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$581k 25,000 shares
$23.25
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Director
Holding Value $1.43k 25,000 shares
Last Trade
May 21, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156k 25,000 shares
$6.22
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Director
Holding Value $1.43k 25,000 shares
Last Trade
May 23, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$407k 25,000 shares
$16.27
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Director
Holding Value $570 10,000 shares
Last Trade
Jul 20, 2018 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$265k 10,000 shares
$26.54
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Director
Holding Value $0 0 shares
Last Trade
Jul 17, 2018 Sale
No data
No data
$0.06
Rubius Therapeutics
Rubius Therapeutics RUBY
Director
Holding Value $1.43k 25,000 shares
Last Trade
Jul 17, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.06
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $17.6M 321,905 shares
Last Trade
Mar 10, 2017 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.01M 34,452 shares
$58.32
$54.72
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $948k 17,318 shares
Last Trade
Mar 10, 2017 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.89M 66,726 shares
$58.32
$54.72
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $19M 346,769 shares
Last Trade
Mar 10, 2017 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.89M 66,726 shares
$58.32
$54.72
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $16.3M 297,112 shares
Last Trade
Mar 10, 2017 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$80.7k 1,384 shares
$58.32
$54.72
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $16.5M 301,378 shares
Last Trade
Mar 10, 2017 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$86.5k 1,484 shares
$58.32
$54.72
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $15.9M 289,731 shares
Last Trade
Jul 01, 2016 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$140k 1,896 shares
$73.78
$54.72
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $400k 7,308 shares
Last Trade
Jul 01, 2016 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$270k 3,655 shares
$73.78
$54.72
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $16M 291,627 shares
Last Trade
Jul 01, 2016 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$270k 3,655 shares
$73.78
$54.72
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $15.2M 277,114 shares
Last Trade
Mar 10, 2016 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$207k 3,185 shares
$64.94
$54.72
Bristol-Myers Squibb
Bristol-Myers Squibb BMY
EVP & CSO
Holding Value $15.3M 278,892 shares
Last Trade
Mar 10, 2016 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$5.07k 78 shares
$64.94
$54.72

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up